MEMBRANE: Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas with TRUFILL® n-BCA

This is a prospective, multi-center, open-label, randomized controlled study designed to evaluate the effectiveness and safety of Middle Meningeal Artery Embolization utilizing TRUFILL n-BCA for the treatment of Chronic Subdural Hematomas.

We are recruiting participants aged 18-90. 

Sponsor(s)
Cerenovus
Principal Investigator(s)
Dimitri Sigounas, MD
Contact Phone Number
Request Information